Submit to Special Issue Submit Abstract to Special Issue Review for Pharmaceuticals Propose a Special Issue

Journal Menu

Journal Browser

► Journal Browser

Special Issue "Metal Nanoparticles’ Biological Activity and Pharmaceutical Applications"

Special Issue Editors
Special Issue Information
Keywords
Published Papers

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: 22 December 2023 | Viewed by 2836

Share This Special Issue

Special Issue Editors

Dr. Elitsa L. Pavlova

E-Mail Website
Guest Editor

Biophysics and Medical Physics Group, Optics and Spectroscopy Department, Faculty of Physics, Sofia University "St. Kliment Ohridski", 5 James Boucher Blvd., 1164 Sofia, Bulgaria
Interests: biophysics; physiology; cell biology; disease; oxidative stress; reactive oxygen species (ROS); antioxidants; antioxidant enzymes; pharmaceuticals; nanoparticles

Prof. Dr. Debbie C. Crans

E-Mail Website
Guest Editor

Department of Chemistry, Colorado State University, Fort Colllins, CO 80523, USA
Interests: vanadium; metals in medicine; drugs and biologically active compounds; lipid and lipid model interfaces; pharmaceutically active compounds; cancer; diabetes; tuberculosis; hydrophobic compounds; spectroscopy; transition metals; reverse micelles; chemistry in confined spaces
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Nanoparticles have been the subject of numerous studies because of their specific physicochemical characteristics, which make them suitable for introduction and application in living systems. The ability of metal nanoparticles to interact with cells, as well as their structures and cellular metabolites, is of particular importance in their applications as drug carriers, and in the diagnosis and treatment of various diseases. The properties of the nanoparticles depend strongly on their shape, size and material. One of the problems with their practical applications in living organisms is their toxicity.

Usually, two basic approaches are applied in the evaluation of the harmful effects of the nanoparticles prepared from metals and other materials—the measurement of their cytotoxic and/or antibacterial effects.

Compounds with cytotoxic effects often damage the permeability and structure of the cell membrane and/or cell metabolism. Cytotoxicity can be measured using various methods and cell cultures, depending on the focus of the research. One quite informative approach is the registration of the kinetics of the cytotoxic response, instead of the snapshot used in the colorimetric standard endpoint assays.

The evaluation of the antibacterial activity applies traditional microbiological assays to test the safety of the metal nanoparticles against some of the most common Gram-positive and Gram-negative bacteria. These tests are very suitable for establishing a sensitivity scale, especially when testing newly synthesized nanomaterials.

Another set of very informative reactions describing the safety of metal nanomaterials is their redox activity, and especially effects on oxidative stress. Free radical reactions and generation of ROS are vital metabolic responses that ensure the body’s homeostasis, functional activity and adaptation. The speed of these reactions is maintained by a complex system of regulation, and its imbalance is a universal mechanism and cause for the development of acute and chronic diseases.

Let’s dive into the metal nanoworld! I look forward to your valuable contribution with the description of the biological activities and applications of metal nanoparticles, their combinations with natural or synthetic substances or their applications as drug and diagnostic tools!

Dr. Elitsa L. Pavlova
Prof. Dr. Debbie C. Crans
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

metal nanoparticles
redox reactions
biological activity
pharmaceuticals
cytotoxicity
antibacterial effect
oxidative stress
disease
safety
in vivo applications

Published Papers (4 papers)

Download All Papers

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

Jump to: Review

20 pages, 4586 KiB

Open AccessArticle

Green Synthesis and Characterization of Silver Nanoparticles Using Azadirachta indica Seeds Extract: In Vitro and In Vivo Evaluation of Anti-Diabetic Activity

Abdulwahed Fahad Alrefaei

Mikhlid H. Almutairi

Yong-Sun Moon

and

Sajid Ali

Pharmaceuticals 2023, 16(12), 1677; https://doi.org/10.3390/ph16121677 - 01 Dec 2023

Viewed by 226

Abstract

Background: Diabetes mellitus (DM) is a non-communicable, life-threatening syndrome that is present all over the world. The use of eco-friendly, cost-effective, and green-synthesised nanoparticles as a medicinal therapy in the treatment of DM is an attractive option. Objective: In the present study, silver nanoparticles (AI-AgNPs) were biosynthesized through the green synthesis method using Azadirachta indica seed extract to evaluate their anti-diabetic potentials. Methods: These nanoparticles were characterized by using UV-visible spectroscopy, Fourier transform infrared spectrophotometers (FTIR), scanning electron microscopy (SEM), DLS, and X-ray diffraction (XRD). The biosynthesized AI-AgNPs and crude extracts of Azadirachta indica seeds were evaluated for anti-diabetic potentials using glucose adsorption assays, glucose uptake by yeast cells assays, and alpha-amylase inhibitory assays. Results: Al-AgNPs showed the highest activity (75 ± 1.528%), while crude extract showed (63 ± 2.5%) glucose uptake by yeast at 80 µg/mL. In the glucose adsorption assay, the highest activity of Al-AgNPs was 10.65 ± 1.58%, while crude extract showed 8.32 ± 0.258% at 30 mM, whereas in the alpha-amylase assay, Al-AgNPs exhibited the maximum activity of 73.85 ± 1.114% and crude extract 65.85 ± 2.101% at 100 µg/mL. The assay results of AI-AgNPs and crude showed substantial dose-dependent activities. Further, anti-diabetic potentials were also investigated in streptozotocin-induced diabetic mice. Mice were administered with AI-AgNPs (10 to 40 mg/kg b.w) for 30 days. Conclusions: The results showed a considerable drop in blood sugar levels, including pancreatic and liver cell regeneration, demonstrating that AI-AgNPs have strong anti-diabetic potential. Full article

(This article belongs to the Special Issue Metal Nanoparticles’ Biological Activity and Pharmaceutical Applications)

► Show Figures

Figure 1

16 pages, 3014 KiB

Open AccessArticle

Process Optimization for the Bioinspired Synthesis of Gold Nanoparticles Using Cordyceps militaris, Its Characterization, and Assessment of Enhanced Therapeutic Efficacy

and

Pharmaceuticals 2023, 16(9), 1311; https://doi.org/10.3390/ph16091311 - 16 Sep 2023

Viewed by 629

Abstract

The promising therapeutic implications of nanoparticles have spurred their development for biomedical applications. An eco-friendly methodology synthesizes gold nanoparticles using Cordyceps militaris, an edible mushroom (Cord-Au-NPs), using a quality-by-design approach (central composite design). UV-visible spectroscopy analysis revealed an absorption peak at 540–550 nm, thus confirming the synthesis of gold nanoparticles. Cord-Au-NPs have a crystalline structure, as evidenced by the diffraction peaks. The zeta potential value of −19.42 mV signifies the stability of Cord-Au-NPs. XRD study shows gold facets and EDX analysis revealed a strong peak of spherical nanoparticles in the gold region with a mean particle size of 7.18 nm and a polydispersity index of 0.096. The obtained peaks are closely associated with phenolic groups, lipids, and proteins, as examined by FTIR, suggesting that they function as the reducing agent. Cord-Au-NPs exhibited dose-dependent antioxidant, antidiabetic, and antibacterial activity. The method is eco-friendly, nontoxic, less time-consuming, and does not use synthetic materials, leading to higher capabilities in biomedical applications. Full article

(This article belongs to the Special Issue Metal Nanoparticles’ Biological Activity and Pharmaceutical Applications)

► Show Figures

Graphical abstract

25 pages, 3834 KiB

Open AccessArticle

In Vitro, Oral Acute, and Repeated 28-Day Oral Dose Toxicity of a Mixed-Valence Polyoxovanadate Cluster

Mariana de M. Barbosa

Lidiane M. A. de Lima

Widarlane A. da S. Alves

Eucilene K. B. de Lima

and

Pharmaceuticals 2023, 16(9), 1232; https://doi.org/10.3390/ph16091232 - 30 Aug 2023

Viewed by 503

Abstract

Polyoxovanadates (POV) are a subgroup of polyoxometalates (POM), which are nanosized clusters with reported biological activities. This manuscript describes the first toxicity evaluation of a mixed-valence polyoxovanadate, pentadecavanadate, (Me₄N)₆[V₁₅O₃₆Cl], abbreviated as V₁₅. Cytotoxicity experiments using peripheral blood mononuclear cells (PBMC), larvae of Artemia salina Leach, and in vivo oral acute and repeated 28-day doses in mice was carried out. The LC₅₀ values in PBMC cells and A. salina were 17.5 ± 5.8 μmol L⁻¹, and 17.9 µg L⁻¹, respectively, which indicates high cytotoxic activity. The toxicity in mice was not observed upon acute exposure in a single dose, however, the V₁₅ repeated 28-day oral administration demonstrated high toxicity using 25 mg/kg, 50 mg/kg and, 300 mg/kg doses. The biochemical and hematological analyses during the 28-day administration of V₁₅ showed significant alteration of the metabolic parameters related to the kidney and liver, suggesting moderate toxicity. The V₁₅ toxicity was attributed to the oxidative stress and lipid peroxidation, once thiobarbituric acid (TBAR) levels significantly increased in both males and females treated with high doses of the POV and also in males treated with a lower dose of the POV. This is the first study reporting a treatment-related mortality in animals acutely administrated with a mixed-valence POV, contrasting with the well-known, less toxic decavanadate. These results document the toxicity of this mixed-valence POV, which may not be suitable for biomedical applications. Full article

(This article belongs to the Special Issue Metal Nanoparticles’ Biological Activity and Pharmaceutical Applications)

► Show Figures

Figure 1

Review

Jump to: Research

42 pages, 2855 KiB

Open AccessReview

Current Overview of Metal Nanoparticles’ Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles

Anca Florentina Bucur

and

Monica Hancianu

Pharmaceuticals 2023, 16(10), 1410; https://doi.org/10.3390/ph16101410 - 04 Oct 2023

Cited by 1 | Viewed by 1085

Abstract

Metal nanoparticles (NPs) have garnered considerable attention, due to their unique physicochemical properties, that render them promising candidates for various applications in medicine and industry. This article offers a comprehensive overview of the most recent advancements in the manufacturing, characterization, and biomedical utilization of metal NPs, with a primary focus on silver and gold NPs. Their potential as effective anticancer, anti-inflammatory, and antimicrobial agents, drug delivery systems, and imaging agents in the diagnosis and treatment of a variety of disorders is reviewed. Moreover, their translation to therapeutic settings, and the issue of their inclusion in clinical trials, are assessed in light of over 30 clinical investigations that concentrate on administering either silver or gold NPs in conditions ranging from nosocomial infections to different types of cancers. This paper aims not only to examine the biocompatibility of nanomaterials but also to emphasize potential challenges that may limit their safe integration into healthcare practices. More than 100 nanomedicines are currently on the market, which justifies ongoing study into the use of nanomaterials in medicine. Overall, the present review aims to highlight the potential of silver and gold NPs as innovative and effective therapeutics in the field of biomedicine, citing some of their most relevant current applications. Full article

(This article belongs to the Special Issue Metal Nanoparticles’ Biological Activity and Pharmaceutical Applications)

► Show Figures

Journal Menu

Journal Browser

Special Issue "Metal Nanoparticles’ Biological Activity and Pharmaceutical Applications"

Share This Special Issue

Special Issue Editors

Special Issue Information

Keywords

Published Papers (4 papers)

Research

Review

Further Information

Guidelines

MDPI Initiatives

Follow MDPI